Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States

Current Medical Research and Opinion, 2016 03; 32(7): 1233-1241

We compared the real-world effectiveness of initiating adalimumab and infliximab among patients in the US who were naïve to tumor necrosis factor (TNF) inhibitors.

View abstract

Authors

Sandborn WJ, Sakuraba A, Wang A, Macaulay D, Reichmann W, Wang S, Chao J, Skup M.